24,691 Shares in The Procter & Gamble Company (NYSE:PG) Bought by Chiron Investment Management LLC

Chiron Investment Management LLC purchased a new position in The Procter & Gamble Company (NYSE:PG - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,691 shares of the company's stock, valued at approximately $4,276,000. Procter & Gamble accounts for 1.5% of Chiron Investment Management LLC's investment portfolio, making the stock its 28th biggest position.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Acorn Creek Capital LLC lifted its position in Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company's stock worth $376,000 after acquiring an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. grew its position in Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company's stock valued at $963,000 after buying an additional 59 shares during the last quarter. Hudson Value Partners LLC increased its stake in Procter & Gamble by 4.1% in the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company's stock valued at $250,000 after buying an additional 60 shares during the period. Traveka Wealth LLC raised its position in Procter & Gamble by 1.7% during the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company's stock worth $616,000 after buying an additional 60 shares during the last quarter. Finally, Allen Mooney & Barnes Investment Advisors LLC lifted its stake in shares of Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company's stock worth $1,507,000 after acquiring an additional 61 shares during the period. 65.77% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on PG. JPMorgan Chase & Co. increased their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an "overweight" rating in a report on Thursday, September 19th. Barclays cut Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price target for the company. in a report on Monday, September 30th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. Hsbc Global Res upgraded shares of Procter & Gamble to a "strong-buy" rating in a research report on Friday, October 4th. Finally, DZ Bank upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 price target for the company in a report on Thursday, August 29th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $180.45.

Procter & Gamble Trading Down 0.4 %

Shares of NYSE PG traded down $0.76 during midday trading on Wednesday, reaching $171.52. 2,059,618 shares of the stock were exchanged, compared to its average volume of 6,696,092. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $180.43. The stock has a 50 day moving average price of $170.70 and a 200-day moving average price of $169.49. The company has a market capitalization of $403.94 billion, a P/E ratio of 29.88, a P/E/G ratio of 3.68 and a beta of 0.44. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business's revenue was down .6% on a year-over-year basis. During the same quarter last year, the firm earned $1.83 earnings per share. Equities research analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.35%. Procter & Gamble's payout ratio is currently 69.48%.

Insider Buying and Selling

In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the business's stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company's stock, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the firm's stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 83,080 shares of company stock valued at $14,629,038. Insiders own 0.18% of the company's stock.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.